Your Article Summary
Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09
Inspire Pharmaceuticals, Inc. announced Inspire scientists and collaborators will present data from the denufosol tetrasodium cystic fibrosis (CF) program in a poster presentation at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) October 15 – 17, 2009 in Minneapolis, MN.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09
AMA meeting: Nap time mandate for on-call residents rejected
American Medical News , 11/25/09
AMA meeting: Delegate vote refines AMA stance on system reform
American Medical News , 11/25/09
Article Search
Sponsor


See Latest Articles


